{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:05:48Z","timestamp":1792029948935,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.cgh.2009.05.033","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T05:59:16Z","timestamp":1244699956000},"page":"1104-1112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1436,"title":["Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Amy G.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Lydecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent N.","family":"Tetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Contos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2009.05.033_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cld.2004.04.013","article-title":"The histologic spectrum of nonalcoholic fatty liver disease","volume":"8","author":"Contos","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2009.05.033_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2004.09.012","article-title":"The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies","volume":"42","author":"Adams","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2009.05.033_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib8","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2009.05.033_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpgasthep1025","article-title":"Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography","volume":"5","author":"Pinzani","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2009.05.033_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-6-6","article-title":"Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Ratziu","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2009.05.033_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.21984","article-title":"Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers","volume":"47","author":"Guha","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1148\/radiol.2452061673","article-title":"Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index","volume":"245","author":"Huwart","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2009.05.033_bib13","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.3748\/wjg.v12.i27.4325","article-title":"Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers","volume":"12","author":"Kawamoto","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2009.05.033_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.dld.2007.10.019","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Yoneda","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2009.05.033_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/14737159.5.1.15","article-title":"FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?","volume":"5","author":"Poynard","year":"2005","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cgh.2009.05.033_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib17","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2009.05.033_bib18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","article-title":"Liver fibrosis in overweight patients","volume":"118","author":"Ratziu","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2009.05.033_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1478-3231.2005.01064.x","article-title":"Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease","volume":"25","author":"Suzuki","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2009.05.033_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3748\/wjg.v11.i2.255","article-title":"Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"11","author":"Sakugawa","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2009.05.033_bib21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","article-title":"Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease","volume":"57","author":"Harrison","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2009.05.033_bib22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.20842","article-title":"Histopathology of pediatric nonalcoholic fatty liver disease","volume":"42","author":"Schwimmer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1073191194001001004","article-title":"Comparison of timeline follow-back and averaging methods for quantifying alcohol consumption in treatment research","volume":"1","author":"Cervantes","year":"1994","journal-title":"Assessment"},{"key":"10.1016\/j.cgh.2009.05.033_bib26","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1360-0443.1995.tb03552.x","article-title":"The AUDIT questionnaire: choosing a cut-off score","volume":"90","author":"Conigrave","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.cgh.2009.05.033_bib27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/01.ALC.0000128239.87611.F5","article-title":"Validity of the alcohol use disorders identification test in college students","volume":"28","author":"Kokotailo","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cgh.2009.05.033_bib28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib29","first-page":"1302","article-title":"Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection","volume":"92","author":"Bonacini","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2009.05.033_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2893.2006.00736.x","article-title":"Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies","volume":"13","author":"Bourliere","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cgh.2009.05.033_bib31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/00365520510015674","article-title":"Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers","volume":"40","author":"Islam","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2009.05.033_bib32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2036.2006.03034.x","article-title":"Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C","volume":"24","author":"Borroni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2009.05.033_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2036.2008.03672.x","article-title":"Review article: nonalcoholic fatty liver disease and hepatitis C virus\u2014partners in crime","volume":"27","author":"Blonsky","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2009.05.033_bib34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/hep.20818","article-title":"Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women","volume":"42","author":"Kunde","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method for comparing the area under the receiver operating curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2009.05.033_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.artmed.2008.01.001","article-title":"Assessment of classification improvement in patients with Alzheimer's disease based on magnetoencephalogram blind source separation","volume":"43","author":"Escudero","year":"2008","journal-title":"Artif Intell Med"},{"key":"10.1016\/j.cgh.2009.05.033_bib37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neunet.2007.12.012","article-title":"Classifier performance estimation under the constraint of a finite sample size: Resampling schemes applied to neural network classifiers","volume":"21","author":"Sahiner","year":"2008","journal-title":"Neural Netw"},{"key":"10.1016\/j.cgh.2009.05.033_bib38","doi-asserted-by":"crossref","first-page":"Article12","DOI":"10.2202\/1544-6115.1363","article-title":"A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry","volume":"7","author":"Valkenborg","year":"2008","journal-title":"Stat Appl Genet Mol Biol"},{"key":"10.1016\/j.cgh.2009.05.033_bib39","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s001340050618","article-title":"The Apache III prognostic system: customized mortality predictions for Spanish ICU patients","volume":"24","author":"Rivera-Fernandez","year":"1998","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cgh.2009.05.033_bib40","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.05.033_bib41","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages","volume":"53","author":"Poynard","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.cgh.2009.05.033_bib42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2036.2006.03182.x","article-title":"Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia","volume":"25","author":"Ratziu","year":"2007","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356509005333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356509005333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:05:31Z","timestamp":1761541531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356509005333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1542356509005333"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2009.05.033","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2009.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}